CM
PHVS icon

Crestline Management’s Pharvaris PHVS Stock Holding History

Crestline Management’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,819
Closed -$293K – 848
2024
Q3 		$293K Buy
+15,819
New +$289K 0.02% 460

Other funds holding PHVS

GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Crestline Management's PHVS Position: Q4 2024 in Review

Crestline Management sold out of Pharvaris (PHVS) in Q4 2024, closing a stake of 15,819 shares — an estimated $293K sold.

Crestline Management first reported a position in PHVS in Q3 2024 and held it in 1 quarter. The position peaked at $293K in Q3 2024. 54 funds tracked by Wall St. Rank hold PHVS as of Q4 2024.

  • Crestline Management reported no remaining Pharvaris position as of Q4 2024 after selling out during the quarter.
  • Crestline Management sold 15,819 Pharvaris shares in Q4 2024, an estimated $293K.
  • Crestline Management first reported a position in Pharvaris in Q3 2024 and held it in 1 quarter.
  • Crestline Management's Pharvaris position peaked at $293K in Q3 2024.
  • 54 funds tracked by Wall St. Rank held Pharvaris as of Q4 2024.

Based on Crestline Management's 13F filing for Q4 2024, filed 14 Feb 2025.